Parasitic and anaerobic bacterial DNA (DNA)

Parasitic and anaerobic bacterial DNA is the primary molecular target for the nitroimidazole class of antimicrobial agents, including metronidazole and tinidazole (StatPearls, NBK539728). These drugs function as prodrugs that are selectively activated in anaerobic environments through the reduction of their nitro group by microbial electron transport proteins, such as ferredoxin or pyruvate:ferredoxin oxidoreductase (PubChem, CID 4173). This reductive process generates short-lived, highly reactive nitroso-free radical intermediates that form covalent bonds with DNA bases. The resulting chemical modification leads to the destabilization of the DNA helical structure, extensive strand breakage, and the inhibition of essential nucleic acid synthesis (PubMed, PMID 10403111). Because the activation of these drugs requires a very low oxidation-reduction potential, the mechanism is highly specific to anaerobic bacteria and certain protozoan parasites, sparing aerobic host cells. This target is clinically significant for the treatment of infections such as trichomoniasis, giardiasis, and various anaerobic bacterial infections including those caused by Bacteroides and Clostridioides species.

Other names

Microbial DNAAnaerobic DNAProtozoal DNABacterial DNA

Reductive activation of nitroimidazole prodrugs by microbial electron transport proteins generates reactive radical intermediates that cause DNA strand breakage and inhibit nucleic acid synthesis.